Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Warburtons gluten free brown rolls
0913271B0BHAAAT
|
Warburtons specialist food replacer rolls/baguettes | Specialist food replacer rolls/baguettes (0913271) | Nutrition and Blood | 836 |
|
ActivHeal Hydrogel dressing
20030500080
|
ActivHeal Hydrogel dressing | Wound Management & Other Dressings | Dressings | 835 |
|
Metalline tracheostomy dressing 8cm x 9cm
20050400105
|
Metalline tracheostomy dressing 8cm x 9cm | Tracheostomy & Laryngectomy Appliances | Dressings | 835 |
|
Pradaxa 110mg capsules
0208020X0BBABAB
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | 835 |
|
Paracetamol 1g effervescent tablets sugar free
0407010H0AADUDU
|
Paracetamol | Paracetamol | Central Nervous System | 834 |
|
Valproic acid 300mg gastro-resistant capsules
040801020AAABAB
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 834 |
|
Aloflute 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BJABBG
|
Aloflute | Fluticasone propionate (Inhalation) | Respiratory System | 833 |
|
Opiodur 75micrograms/hour transdermal patches (Zentiva)
0407020A0BRANAG
|
Opiodur | Fentanyl | Central Nervous System | 833 |
|
PF Drops Hypromellose 0.3% eye drops preservative free
21300000159
|
PF Drops Hypromellose 0.3% eye drops preservative free | Eye Products | Appliances | 833 |
|
Ceyesto 3mg tablets
0401010ADBFAACY
|
Ceyesto | Melatonin | Central Nervous System | 831 |
|
CoAprovel 150mg/12.5mg tablets
0205052A0BBAAAA
|
Coaprovel | Irbesartan with diuretic | Cardiovascular System | 831 |
|
DulcoEase 100mg capsules
0106020I0BGAAAK
|
DulcoEase | Docusate sodium | Gastro-Intestinal System | 829 |
|
Ensure Plus Commence liquid assorted
0913011N0BEABAA
|
Ensure ready to serve 1.5 kcal/ml milkshake | Ready to serve 1.5 kcal/ml milkshake (0913011) | Nutrition and Blood | 828 |
|
LINC all silicone catheter with integral balloon and glycerine filled syringe standard 14Ch 5ml
21020001419
|
LINC all silicone catheter with integral balloon and glycerine filled syringe standard 14Ch 5ml | Catheters | Appliances | 828 |
|
Xgeva 120mg/1.7ml solution for injection vials
0606020Z0BCAAAB
|
Xgeva | Denosumab | Endocrine System | 828 |
|
Sastravi 200mg/50mg/200mg tablets
0409010X0BCAGAD
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 827 |
|
Trandate 200mg tablets
0204000I0BCACAD
|
Trandate | Labetalol hydrochloride | Cardiovascular System | 827 |
|
Tubigrip bandage 7.5cm size D
20090000215
|
Tubigrip bandage 7.5cm size D | Stockinette | Dressings | 827 |
|
Epilim Chronosphere MR 50mg granules sachets
0408010W0BBANBV
|
Epilim | Sodium valproate | Central Nervous System | 826 |
|
Mylife Safety Comfort lancets 0.32mm/30gauge
21010900890
|
Mylife Safety Comfort lancets 0.32mm/30gauge | Other Appliances | Appliances | 826 |
|
OpSite Post-Op dressing 10cm x 12cm
20030100552
|
OpSite Post-Op dressing 10cm x 12cm | Wound Management & Other Dressings | Dressings | 826 |
|
Juvela gluten free fresh white rolls
0913271B0BEADAL
|
Juvela specialist food replacer rolls/baguettes (G/F) | Specialist food replacer rolls/baguettes (0913271) | Nutrition and Blood | 825 |
|
Innovace 2.5mg tablets
0205051I0BBAAAA
|
Innovace | Enalapril maleate | Cardiovascular System | 824 |
|
Juzo Expert custom fit class 1 (18-21mmHg) below knee
21270001390
|
Juzo Expert custom fit class 1 (18-21mmHg) below knee | Lymphoedema Garments | Appliances | 824 |
|
kliniderm Foam Silicone Border dressing 10cm x 20cm
20030900248
|
kliniderm Foam Silicone Border dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | 824 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.